BIOMAT Database Logo BIOMAT Database Logo

Clinical evaluation of a new measles-mumps-rubella trivalent vaccine. 1975

A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters

In a series of clinical studies of a combined measles (Schwarz strain), mumps (Jeryl Lynn strain), and rubella (Cendehill strain) vaccine, 1,481 children received the vaccine or a placebo. The vaccine did not cause any significant reactions. The frequencies of mild, transient fever or rash or both in triple-susceptible vaccinees were similar to those that follow use of Schwarz strain measles vaccine alone. Measles, mumps, and rubella seroconversion rates in triple-susceptible vaccinees ranged from 95% to 100%. Geometric mean antibody titers were as high as those that usually result from use of these same virus strains as monovalent vaccines.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D009108 Mumps Vaccine Vaccines used to prevent infection by MUMPS VIRUS. Best known is the live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunized with live mumps vaccine. Children are usually immunized with measles-mumps-rubella combination vaccine. Inactivated Mumps Vaccine,Inactivated Mumps Virus Vaccine,Live Attenuated Mumps Vaccine,Live Attenuated Mumps Virus Vaccine,Mumps Vaccine, Inactivated,Mumps Vaccine, Live Attenuated,Mumps Virus Vaccine, Inactivated,Mumps Virus Vaccine, Live Attenuated,Vaccine, Inactivated Mumps,Vaccine, Mumps
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters
Evaluation of a trivalent measles, mumps, rubella vaccine in children.
July 1975, The Journal of pediatrics,
A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters
Clinical trial of a new trivalent measles-mumps-rubella vaccine in young children.
September 1984, American journal of diseases of children (1960),
A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters
[Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
March 1989, Minerva pediatrica,
A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters
Trivalent combined measles-mumps-rubella vaccine. Findings in clinical-laboratory studies.
October 1971, JAMA,
A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters
Field trial of trivalent measles-rubella-mumps vaccine in Japan.
November 1982, The Journal of infectious diseases,
A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters
Effects and side effects of a new trivalent combined measles-mumps-rubella (MMR) vaccine.
September 1982, The Tokai journal of experimental and clinical medicine,
A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters
Measles/mumps/rubella vaccine: a new start.
September 1988, Midwife, health visitor & community nurse,
A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters
Erythema multiforme following live attenuated trivalent measles-mumps-rubella vaccine.
January 2006, Acta dermato-venereologica,
A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters
Measles/mumps/rubella vaccine.
October 1988, Lancet (London, England),
A J Schwarz, and J E Jackson, and N J Ehrenkranz, and A Ventura, and G M Schiff, and V W Walters
[A comparative study of 3 different types of trivalent measles-mumps-rubella vaccine].
January 1992, La Pediatria medica e chirurgica : Medical and surgical pediatrics,
Copied contents to your clipboard!